Palbace 125mg Tablet

PRODUCT INTRODUCTION

Palbace 125mg Tablet contains the active ingredient palbociclib, a targeted therapy specifically developed to manage hormone receptor-positive, HER2-negative breast cancer, which is commonly seen in postmenopausal women. This drug belongs to a class of medications known as cyclin-dependent kinase (CDK) 4/6 inhibitors. CDKs play a crucial role in cell cycle regulation, and by inhibiting these enzymes, Palbace effectively halts cancer cell growth.

This tablet is often prescribed alongside hormonal therapies such as letrozole or fulvestrant, as these enhance the efficacy of Palbace. Together, these medications work to slow down cancer cell multiplication and progression, particularly in cases where surgery or other local treatments are no longer feasible. The introduction of CDK 4/6 inhibitors, such as Palbace, has transformed breast cancer treatment by offering a targeted approach with comparatively manageable side effects.

USES OF PALBACE 125MG TABLET

Palbace 125mg Tablet is primarily used for:

• Advanced or Metastatic Breast Cancer: Specifically for patients with hormone receptor-positive, HER2-negative breast cancer. It is administered in advanced or metastatic cases when the cancer has spread beyond the breast and nearby lymph nodes, making traditional treatments challenging.
• Combination Therapy: It is often combined with endocrine therapies to achieve enhanced anti-cancer effects. When combined, the two therapies reduce tumor size and delay progression, especially in cases resistant to initial hormone treatments.
• Preventing Disease Progression: Palbace is used to extend the period during which the cancer remains stable, improving survival rates and reducing the likelihood of rapid disease advancement.

BENEFITS OF PALBACE 125MG TABLET

The Palbace 125mg Tablet offers several important benefits for patients with advanced breast cancer, making it a critical component of treatment plans. Key benefits include:

• Targeted Action: Unlike traditional chemotherapy, Palbace 125mg Tablet selectively targets specific enzymes (CDK4 and CDK6) involved in cancer cell growth. This targeted approach results in fewer off-target effects, thus reducing the overall toxicity of treatment.
• Prolonged Progression-Free Survival: Clinical trials have demonstrated that Palbace, when used with hormone therapy, significantly extends the time before disease progression. Patients experience longer periods of stable disease, allowing them to maintain their normal activities for a longer duration.
• Enhanced Efficacy in Combination with Hormonal Therapies: Palbace works in synergy with hormone therapy, helping to improve patient outcomes. The combination approach can effectively delay the need for chemotherapy and its associated side effects, providing an alternative to patients who have not responded well to hormonal therapies alone.
• Fewer Adverse Effects Compared to Chemotherapy: Palbace generally causes fewer side effects than chemotherapy. Patients taking Palbace may experience less severe nausea, hair loss, and other common side effects associated with chemotherapy, making it a well-tolerated choice for long-term treatment.
• Improved Quality of Life: With prolonged disease control and relatively manageable side effects, Palbace can help improve quality of life for patients. This is especially significant for those in advanced cancer stages, as it allows them more time with family and friends, along with greater physical well-being during treatment.

SIDE EFFECTS OF PALBACE 125MG TABLET

While Palbace 125mg Tablet is generally well-tolerated, some patients may experience side effects. It is important for patients and caregivers to monitor symptoms and consult healthcare providers if side effects become bothersome or severe. Common side effects include:

• Hematological Side Effects: Palbace commonly affects blood cell counts, leading to conditions such as neutropenia (low white blood cell count), anemia (low red blood cell count), and thrombocytopenia (low platelet count). Regular blood tests are necessary to monitor these levels.
• Fatigue: Many patients experience fatigue, which may range from mild to severe. Fatigue is a common effect of cancer treatments and may impact daily activities. Rest and proper nutrition can help manage this side effect.
• Nausea and Vomiting: While less frequent than with traditional chemotherapy, some patients may experience nausea and vomiting. These symptoms can usually be managed with anti-nausea medications.
• Diarrhea: Palbace can cause digestive issues like diarrhea. Staying hydrated and following a bland diet can often alleviate these symptoms.
• Infections: Due to lowered white blood cell counts, patients are at a higher risk of infections, particularly respiratory infections. Patients should promptly report any symptoms of infection, such as fever, to their healthcare provider.
• Mouth Sores: Some patients experience oral mucositis or sores in the mouth. These sores can make eating and drinking uncomfortable and may require medical treatment to prevent infection.

FAQ

Q1. How should I take Palbace 125mg Tablet?
A: Palbace is typically taken once daily with food, following a specific dosage cycle prescribed by your doctor. The cycle usually involves three weeks of medication followed by a one-week break. It’s important not to crush or chew the tablet and to follow your healthcare provider’s instructions closely.

Q2. Can I take Palbace 125mg Tablet with other medications?
A: Certain medications may interact with Palbace, potentially reducing its effectiveness or increasing side effects. Be sure to inform your doctor about any other medications you are taking, including over-the-counter drugs and supplements.

Q3. What should I do if I miss a dose of Palbace 125mg Tablet?
A: If you miss a dose, take it as soon as you remember unless it’s close to the time for your next dose. Do not double the dose to make up for a missed one. It’s best to set reminders to ensure consistent medication intake.

Q4. Are there any dietary restrictions while taking Palbace 125mg Tablet?
A: Patients should avoid grapefruit and grapefruit juice, as these can interfere with the drug’s effectiveness. Additionally, following a balanced diet rich in nutrients can help manage side effects and support overall health during treatment.

Q5. How long will I need to take Palbace 125mg Tablet?
A: The duration of treatment depends on your response to the medication and the progression of your cancer. Some patients may take Palbace for several months or years, while others may discontinue based on side effects or efficacy.

Q6. Is Palbace safe for pregnant or breastfeeding women?
A: Palbace is not recommended for use during pregnancy or breastfeeding due to potential risks to the baby. Women of reproductive age should discuss contraception with their doctor while on Palbace.

Q7. What should I do if I experience severe side effects?
A: If you experience any severe side effects, such as a fever or signs of infection, seek medical attention immediately. Your healthcare provider may adjust your dosage or provide medications to manage symptoms.

Q8. Can Palbace cure breast cancer?
A: While Palbace does not cure breast cancer, it can significantly slow disease progression and extend survival in advanced stages. It is used to manage symptoms and improve quality of life.

Disclaimer

Singhla Medicos primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.